Tag: Access to medicines
-
Australia’s Medicinal Cannabis Crisis: Government in a Bind
Australia’s Medicinal Cannabis Crisis: A policy squeeze Across Australia, patients relying on medicinal cannabis face renewed uncertainty as a small cadre of doctors are sidelined and regulators tighten oversight. The Medical Board of Australia recently banned a prominent prescriber, Dr. Justin Welsh, from continuing to prescribe cannabis. His appeal, described by Welsh as a protest…
-
India-Botswana Pharma MoU expands medicine access worldwide
Strengthening Medicine Access Through Partnership During President Droupadi Murmu’s state visit, India and Botswana formalized a landmark pharmaceutical cooperation agreement aimed at expanding access to medicines and addressing persistent drug shortages in Botswana. The memorandum of understanding (MoU) signals a strategic shift in health diplomacy, leveraging India’s robust pharmaceutical sector to support Botswana’s health emergency…
-
India and Botswana Sign MoU to Expand Access to Medicines
Overview: A notable stride in health diplomacy In a bid to tackle ongoing medicine shortages in Botswana and strengthen regional health security, India and Botswana signed a memorandum of understanding (MoU) on expanding access to medicines during President Droupadi Murmu’s state visit. The agreement aligns with shared goals of improving drug availability, ensuring quality standards,…
-
Lenacapavir PrEP Price Drop: From $28,000 to $40 Expands Access
What is Lenacapavir and how does it work as PrEP? Lenacapavir is a long-acting HIV prevention drug (PrEP) that is administered as an injection twice a year. In the European Union, it has been approved for preventive use under the brand name Yeytuo, with Gilead as the manufacturer. Early studies have shown near-total protection against…